Zum Inhalt

Journal of Cancer Research and Clinical Oncology

Ausgabe 6/2024

Inhalt (45 Artikel)

Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes

  • Open Access
  • Research

Zitao Li, Qiqi Xie, Fuxing Zhao, Xinfa Huo, Dengfeng Ren, Zhilin Liu, Xiaofeng Zhou, Guoshuang Shen, Jiuda Zhao

Long-term outcomes and prognosis of neuroendocrine neoplasms of the head and neck: a cohort from a single institution

  • Open Access
  • Research

Xinqi Shi, Xiaodong Huang, Kai Wang, Yuan Qu, Xuesong Chen, Runye Wu, Ye Zhang, Jianghu Zhang, Jingwei Luo, Jingbo Wang, Junlin Yi

Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting

  • Open Access
  • Research

Yanying Li, Yuming Wan, Xiaoyun Yang, Ping Chen, Yan Gui, Lang He, Yingwei Xie, Jing Tian, Ping Duan, Guangguo Liu, Yu Sun, Jiang Zhu

Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II–III triple negative breast cancer: a retrospective analysis

  • Open Access
  • Research

Huibo Wang, Nana Zhang, Qi Sun, Ziqi Zhao, Hui Pang, Xiatian Huang, Ruifeng Zhang, Wenli Kang, Ming Shan

SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression

  • Open Access
  • Research

Chunyuan Luo, Juan He, Yang Yang, Ke Wu, Xin Fu, Jian Cheng, Yue Ming, Wenrong Liu, Yong Peng

LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B

  • Open Access
  • Research

Jie Li, Fang Hou, Zhenghua Teng, Weiwei Xia, Jie Peng

DIAPH2 gene polymorphisms and laryngeal cancer risk in men

  • Open Access
  • Research

Edyta Cichocka, Sylwia Górczyńska-Kosiorz, Maciej Misiołek, Wojciech Ścierski, Anna Koniewska, Grażyna Stryjewska-Makuch, Janusz Gumprecht

Spatial transcriptomics in cancer research and potential clinical impact: a narrative review

  • Open Access
  • Review

Michael A. Cilento, Christopher J. Sweeney, Lisa M. Butler

New T staging recommendations for recurrent nasopharyngeal carcinoma

  • Open Access
  • Research

Mingjing Zhu, Pian Li, Huisi Zhang, Lanhua Wu, Kang Min

Exploring prognostic and immunological characteristics of pancreatic ductal adenocarcinoma through comprehensive genomic analysis of tertiary lymphoid structures and CD8 + T-cells

  • Open Access
  • Research

Hao Hu, Yang Xu, Qiang Zhang, Xiangnan Ai, Tengfei Wang, Huixing Li, Changguo Jin, Caiguo Ouyang, Zhenyu Wu

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for progressive systemic sclerosis: a retrospective study of outcome and prognostic factors

  • Open Access
  • Research

Vanessa Pyka, Deepak B. Vangala, Thomas Mika, Alexander Kreuter, Laura Susok, Xenofon Baraliakos, Hannes Treiber, Roland Schroers, Verena Nilius-Eliliwi

Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6

  • Open Access
  • Research

Jia-Dong Liang, Yu-E Zhang, Fei Qin, Wan-Na Chen, Wen-Mei Jiang, Zeng Fang, Xiao-Li Liang, Quan Zhang, Jie Li

MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation

  • Open Access
  • Research

Xin Cai, Jie Gao, Zhiping Yan, Huapeng Zhang, Danfeng Guo, Shuijun Zhang

Niraparib enhances antitumor immunity and contributes to the efficacy of PD-L1 blockade in cervical cancer

  • Open Access
  • Research

Jie Chang, Shimin Quan, Sijuan Tian, Shirui Wang, Simin Li, Yanping Guo, Ting Yang, Xiaofeng Yang

COMMD10 inhibited DNA damage to promote the progression of gastric cancer

  • Open Access
  • Research

Xiaohua Liu, Xiaocheng Mao, Chao Zhu, Hongfei liu, Yangyang Fang, Tianmei Fu, Linwei Fan, Mengwei Liu, Ziqing Xiong, Hong Tang, Piaoping Hu, Aiping Le

Identification and validation of the role of ZNF281 in 5-fluorouracil chemotherapy of gastric cancer

  • Open Access
  • Research

Yifan Li, Chengying Zhou, Guoxu Wang, Huiru Xin, Yafei Xiao, Changjiang Qin

Hepatic infarction occurred after 125I particle stent treatment for hepatocellular carcinoma with portal vein tumor thrombus: A case report

  • Open Access
  • Case Report

Jiemin Yang, Yang Qin, Zhongyuan Lv, Qingqing Xiao, Ying Miao, Huiping Huang, Bing Wei, Jingsong Mao

Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma

  • Open Access
  • Research

Sijia Zhang, Ping Tuo, Yuanye Ji, Zuoan Huang, Zi Xiong, Hongshan Li, Chunyan Ruan

Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma

  • Open Access
  • Research

Yange Gu, Ensi Ma, Shengran Jiang, Zhenyu Shan, Guixi Xia, Rui Ma, Jiaqi Fu, Zhengxin Wang

Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3

  • Open Access
  • Research

Yu Feng, Rulin Qian, Dong Cui, Jiaqiang Luan, Mingxing Xu, Ling Wang, Ruijie Li, Xiao Wu, Chaoying Chang

Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target

  • Open Access
  • Research

Mingze Xu, Xinyi Ma, Yuchong Wang, Ziqin Yu, Xiaoli Zheng, Haiying Dai, Chunyu Xue

Identification of a novel MEF2C::SS18L1 fusion in childhood acute B-lymphoblastic leukemia

  • Open Access
  • Research

Chuqin Chen, Jiali Wang, Meiyun Kang, Peng Wu, Liwen Zhu, Yongjun Fang, Yao Xue

DNAJC1 facilitates glioblastoma progression by promoting extracellular matrix reorganization and macrophage infiltration

  • Open Access
  • Research

Han Zhang, Wenjing Zheng, Xu Chen, Longqi Sa, Yi Huo, Lingling Zhang, Lequn Shan, Tao Wang

Liver cancer from the perspective of single-cell sequencing: a review combined with bibliometric analysis

  • Open Access
  • Review

Yanwei Ji, Qi An, Xinyu Wen, Zhou Xu, Zhengyuan Xia, Zhongyuan Xia, Qinyong Hu, Shaoqing Lei

LINC00525 enhances ZNF460-regulated CD24 expression through the sponge miR-125a-5p to promote malignant progression of breast cancer

  • Open Access
  • Research

Jun Wang, Ji Shi, Yuan Xiang, Zhi-Wen Wang, Fei-Fei Qi, Zi-Yi Li, Li-Li Zhao, Guan-Hua Zhu, Yuan-Yuan Duan, Zhong-Yi Yang, Jia-Peng Li, Xing-Hua Liao

MEX3A promotes colorectal cancer migration, invasion and EMT via regulating the Wnt/β-catenin signaling pathway

  • Open Access
  • Research

Jiannan Xu, Songyao Chen, Tengfei Hao, Guangyao Liu, Kai Zhang, Changhua Zhang, Yulong He

TREM1+ tumor-associated macrophages secrete CCL7 to promote hepatocellular carcinoma metastasis

  • Open Access
  • Research

Simin Huang, Longguang He, Yufei Zhao, Yuxuan Wei, Qiwen Wang, Yi Gao, Xiaofeng Jiang

Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer

  • Open Access
  • Research

Liu Yuan, Fang Shan-shan, Zhao Run-sheng, Liu Bo, Yi-qiang Jin, Li Quan

Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China

  • Open Access
  • Research

Jing Li, Peng He, Qindong Cai, Lili Chen, Yali Wang, Weifeng Cai, Yibin Qiu, Shunyi Liu, Wenhui Guo, Minyan Chen, Yuxiang Lin, Chuan Wang, Fangmeng Fu

Circular RNA circLIFR suppresses papillary thyroid cancer progression by modulating the miR-429/TIMP2 axis

  • Open Access
  • Research

Fengyuan Zhang, Jiazheng Li, Jingjing Xu, Xugan Jiang, Shengxia Chen, Qais Ahmad Nasser

Mechanistic insights into 125I seed implantation therapy for Cholangiocarcinoma: focus on ROS-Mediated apoptosis and the role of GPX2

  • Open Access
  • Research

Jun Luo, Zheng Yao, Weiren Liang, Danjun Song, Hui Zeng, Yi Jiang, Zhehan Bao, Jiaping Zheng, Yinan Ding

Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis

  • Open Access
  • Research

Wei Gan, Bao-Ye Sun, Zhang-Fu Yang, Cheng Ye, Zhu-Tao Wang, Cheng Zhou, Guo-Qiang Sun, Yong Yi, Shuang-Jian Qiu

Angiosarcoma: clinical outcomes and prognostic factors, a single-center analysis

  • Open Access
  • Research

Siyer Roohani, Titus Rotermund, Felix Ehret, Tomasz Dziodzio, Armin Jarosch, Frederik Maximilian Schäfer, Anne Flörcken, Silvan Wittenberg, Daniel Zips, David Kaul

Clinical risk factors and cancer risk of thyroid imaging reporting and data system category 4 A thyroid nodules

  • Open Access
  • Research

Jing Cheng, Bing Han, Yingchao Chen, Qin Li, Wenwen Xia, Ningjian Wang, Yingli Lu

New uracil analog as inhibitor/modulator of ABC transporters or/and NF-κB in taxol-resistant MCF-7/Tx cell line

  • Open Access
  • Research

Angelika Długosz-Pokorska, Tomasz Janecki, Anna Janecka, Katarzyna Gach-Janczak

Can blood-based markers predict RECIST progression in non-small cell lung cancer treated with immunotherapy?

  • Open Access
  • Research

Melda Yeghaian, Teresa M. Tareco Bucho, Melissa de Bruin, Alexander Schmitz, Zuhir Bodalal, Egbert F. Smit, Regina G. H. Beets-Tan, Daan van den Broek, Stefano Trebeschi

Neu im Fachgebiet Onkologie

Steigert Langzeit-Cannabiskonsum das Risiko für Hodentumoren?

Männer, die regelmäßig oder über viele Jahre Cannabis konsumieren, entwickeln häufiger testikuläre Keimzelltumoren – vor allem nicht-seminomatöse Formen. Darauf verweist eine Analyse von drei Fall-Kontroll- und zwei Beobachtungsstudien.

Akute Zystitis kann auf künftigen Krebs hinweisen

Die Diagnose einer akuten Zystitis im Alter ab 50 Jahren hat sich in einer Studie als nützlicher Prädiktor kommender urogenitaler Krebserkrankungen erwiesen. Besonders hoch ist das Risiko demnach in den ersten drei Monaten nach der Blasenentzündung.

Brustkrebs: Bestrahlung nach Mastektomie verliert an Bedeutung

Auf eine Thoraxwandbestrahlung nach einer Mastektomie können Frauen mit Brustkrebs und einem intermediären Rezidivrisiko heutzutage offenbar verzichten: In der Phase-3-Studie SUPREMO minderte die Bestrahlung nicht das Sterberisiko.

Wirksamkeit im Vergleich: Abirateron und Enzalutamid bei mHSPC

Bei metastasiertem hormonsensitivem Prostatakarzinom (mHSPC) werden häufig die Hemmstoffe des Androgenrezeptorpfades (ARPI) Abirateron und Enzalutamid eingesetzt. Bisher war jedoch unklar, ob sich deren Wirksamkeit unterscheidet. In einer Studie mit US-Veteranen wurden nun Überlebens- und Tumorwachstumsraten unter den beiden ARPI verglichen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Mann raucht Joint/© Daniel Sierralta / Westend61 / stock.adobe.com (Symbolbild mit Fotomodell), Blut in Toilette/© stylefoto24 / stock.adobe.com, Frau hält sich eine Brustseite nach Mastektomie/© chotiga / Stock.adobe.com (Symbolbild mit Fotomodell), Älterer Mann mit Tabletten in der Hand/© vorDa / Getty Images / iStock (Symbolbild mit Fotomodell)